ADHD with anxiety and depression

Comorbidity is the rule

Having only ADHD, and nothing else, is the minority case. Across adult samples, most people who meet criteria for ADHD also meet criteria for at least one other psychiatric condition, and the two that show up most are anxiety and depression. The large epidemiological anchor is the National Comorbidity Survey Replication (Kessler et al. 2006¹), which found that adults with ADHD carried sharply elevated rates of mood and anxiety disorders relative to adults without.

In adult clinical samples the rough numbers land around 30–50% for an anxiety disorder and 20–30% for a depressive disorder at some point, with wide variation by sample and instrument (Katzman et al. 2017²; Sobanski reviews³). Treat those as ranges, not point estimates. The direction of the finding is solid even if the exact percentage shifts study to study: if you have ADHD, the base rate of also having anxiety or depression is high enough that a clinician should be looking for it, and you should not be surprised to find it.

That matters for how you read your own history. An adult who arrives with anxiety and low mood, and treats only those, is statistically likely to be working on a partial picture.

The causal tangle: downstream or primary

A large part of the anxiety and depression that sits on top of ADHD grows out of the ADHD itself — the accumulated residue of living with it untreated for years: the missed deadlines, the half-finished projects, the relationships strained by lateness and forgetfulness, the slow gap that opens between what you intend and what you deliver. That gap produces two things reliably: worry about the next thing going wrong, and demoralisation about the pattern. The longitudinal follow-up work on hyperactive children into adulthood traces exactly this route — secondary mood problems emerging out of years of impairment, not arriving independently (Fischer, Barkley et al.⁴).

When anxiety and depression are downstream like this, they behave like symptoms of an untreated driver. Treat the driver — the ADHD — and the worry and the flatness often lift on their own, because the thing generating them stops generating them. People describe it as the background hum of dread going quiet once the chaos that fed it is under control.

That is not the whole story. Anxiety and depression can also be primary and independent — a major depressive disorder or a generalised anxiety disorder that would be there regardless of the ADHD, running on its own biology and its own course. Both pictures are real, and the same person can have both at once: a primary depression and a layer of ADHD-driven demoralisation on top of it. The distinction is not academic. It decides what you treat, in what order, and what you expect treating the ADHD to do.

The rough test a clinician uses: does the low mood or worry track the ADHD impairment — worse during the chaotic stretches, lifting when things are briefly under control — or does it run on its own clock, present even when life is going well, with the classic features of a primary mood or anxiety disorder? Tracking the impairment points to downstream. Running independently points to primary. Most real cases are a mix, weighted one way or the other.

The misdiagnosis trap

The common adult story runs in the wrong order. Anxiety and depression are visible — they are what the person complains of and what a generalist recognises — so they get named and treated first, sometimes for a decade, while the ADHD underneath stays invisible. The antidepressant helps a little, the anxiety management helps a little, and the core problem never resolves because the thing driving it was never addressed.

This lands hardest on women. The inattentive presentation is quieter, less disruptive, easier to read as anxiety or as a personality trait, and easier to mask — and the result is years of treatment for the secondary conditions before anyone asks the ADHD question (Quinn & Madhoo 2014⁵). The women and ADHD article covers why the diagnosis gets missed and what the female presentation actually looks like. The mechanics of how the masking itself hides the underlying condition — and exhausts the person doing it — are in ADHD masking.

The tell, if you are in this situation: anxiety and depression treatment that has been “sort of working” for years without ever clearing the problem, in someone whose difficulties were there in childhood and run across every area of life rather than tracking specific stressors. That is the pattern that should prompt an ADHD assessment, not another antidepressant switch.

Which to treat first

This is the most practically useful question in the article, and the answer is conditional, not a rule.

The general principle from the adult guidelines: if the ADHD is the driver and the anxiety or depression is secondary to it, treating the ADHD first is often the highest-leverage move, because lifting the ADHD impairment can lift the secondary mood problem with it. The APSARD 2024 US adult guideline⁶ and NICE NG87⁷ both frame treatment of co-occurring conditions as a sequencing question rather than a pick-one question.

The override: when the depression or anxiety is severe, it goes first. Severe depression — the kind with significant anhedonia, hopelessness, or any suicidal ideation — has to be stabilised before ADHD work is even productive, because a person in that state cannot engage with the behavioural and organisational changes that ADHD treatment depends on, and because the safety stakes are higher. The same holds for an anxiety disorder severe enough to be disabling on its own. Stabilise the dangerous or disabling condition first; then treat the ADHD; then see what residual mood or anxiety symptom is left once the driver is handled.

So the order is set by severity and by which condition is driving, roughly:

• Severe or unsafe mood/anxiety — stabilise that first, ADHD second.
• Mild-to-moderate, and looks downstream of ADHD — treat the ADHD first; reassess the mood and anxiety after, since a chunk of it may resolve.
• Both moderate and both clearly independent — they get treated in parallel, often with a stimulant and an antidepressant together (next section).

Stimulants and anxiety, both directions

The thing people are most afraid of, and the thing that is most misunderstood: stimulants and anxiety pull in both directions depending on the person.

In some people a stimulant worsens anxiety directly. The sympathomimetic activation — raised heart rate, the keyed-up edge, sleep disruption if the dose runs too late — reads to an already-anxious nervous system as more anxiety, and the person feels wired and on edge. That is real and it is the basis for the old caution about stimulants in anxious patients.

In other people a stimulant reduces anxiety, and the mechanism is exactly the downstream story above. If the anxiety was being generated by the daily chaos of untreated ADHD — the perpetual sense of being behind, of something important about to be dropped — then quieting the ADHD quiets its source. The chaos that drove the worry stops, and the worry follows. People in this group describe the first weeks on a stimulant as the first time the background dread has gone quiet.

You cannot reliably predict which group someone is in before trying, so the navigation is practical: start low, go slow, and watch which way the anxiety moves over the first weeks. If it worsens, that informs the choice — a lower dose, a longer-acting formulation with a smoother curve, or a non-stimulant such as atomoxetine that does not carry the same activation profile. If it improves, the anxiety was at least partly ADHD-driven and the picture just simplified. The ADHD medication article covers the formulations and how the trial is run.

Combining stimulants and antidepressants

When both conditions are independent and both need treating, a stimulant and an antidepressant are routinely prescribed together. A selective serotonin reuptake inhibitor (SSRI) or serotonin-noradrenaline reuptake inhibitor (SNRI) for the depression or anxiety, plus a stimulant for the ADHD, is a standard and well-tolerated combination in adult practice (Wilens et al.⁹). The two drugs act on different targets and the combination is not, in itself, a problem.

The interactions worth knowing rather than fearing:

• Bupropion is an antidepressant with its own dopaminergic and noradrenergic action, sometimes chosen in this group because it has modest ADHD benefit of its own. It lowers the seizure threshold and stacks stimulant-like activation, so it is watched in anyone with seizure risk or marked anxiety.
• Serotonergic load. The theoretical concern with an SSRI/SNRI plus a stimulant is additive serotonergic and sympathomimetic activation; in practice serotonin syndrome from this specific pairing is rare, but it is the reason a prescriber asks about every other serotonergic agent you take.
• Overlapping side effects. Both classes can disturb sleep, raise heart rate, and reduce appetite. When they are started close together it can be hard to attribute a new side effect to the right drug, which is the practical argument for not starting both on the same day.

None of this makes the combination exotic. It is one of the more common prescriptions in adult ADHD care. The point is that the prescriber needs the full medication list and a clear sequence, not that the two drugs cannot coexist.

When it's bipolar, not unipolar

One distinction sits above all the others for safety: whether the depression is unipolar or part of a bipolar disorder. A stimulant given to someone with undiagnosed bipolar disorder can precipitate or worsen a manic or hypomanic episode, which is why a careful prescriber screens for a history of elevated, expansive, or unusually energised periods — reduced need for sleep, racing thoughts, grandiosity, risky activity — before starting one.

This is harder than it sounds, because ADHD and bipolar disorder share surface features — distractibility, fast speech, restlessness, impulsivity — and an adult can have both. The difference that matters is episodic versus constant: bipolar mood states come in distinct episodes that represent a change from the person’s baseline, while ADHD traits are stable and lifelong. The DSM-5-TR (DSM-5-TR⁸) draws the line on that episodic structure. The differential, and how a clinician distinguishes the conditions that mimic ADHD, is covered in is it ADHD or something else.

The practical instruction: if you have ever had a stretch of days where you needed much less sleep and felt unusually wired, productive, or invincible, tell the prescriber before starting a stimulant. It changes the assessment and the order of treatment — mood stabilisation comes first in bipolar disorder, and stimulants, if used at all, come later and cautiously.

What to do with this

If you are treating anxiety or depression and it has never fully worked, and your difficulties were there in childhood and run across your whole life rather than tracking specific stressors, raise the ADHD question with whoever manages your care. That is the assessment to ask for.

If you already have both diagnoses, the conversation to have with your prescriber is about sequence and about which condition is driving: whether the mood and anxiety look downstream of the ADHD or independent of it, what gets stabilised first, and what they expect treating the ADHD to do to the rest. If there is any history of elevated or wired-up periods, or any current suicidal ideation, those reorder everything and go first.

The related layers are covered elsewhere. The emotional volatility that is part of ADHD itself — distinct from a comorbid mood disorder, though easily confused with one — is in emotional regulation in adult ADHD. The point of holding all of this together is plain: most adults with ADHD have more than one thing going on, and getting the order right is what makes any of the treatments work.